Windham Capital Partners — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Nuvairanuvaira.com in 𝕏Feb 2019 · $79M

Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).

HardwareHealthtechMedical DevicesMinneapolis, US

Martin Mayse(Founder)inSteve Dimmer(Founder)in Dennis Wahr(President & CEO)in Lisa Flaherty(Chief Strategy Officer)in Steve Sathre(Vice President of Finance)inSteve Paidosh(Vice President of Operations)

Co-investorsEndeavour Vision Lightstone Ventures Morgenthaler Qiming Venture Partners Richard King Mellon Foundation Split Rock Partners +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.